M Molimard, CA Martin, E Naline, A Hirsch and C Advenier
Laboratoire de Pharmacologie, Faculte de Medecine Paris Ouest, France.

Bradykinin (Bk) induced a contraction in all small bronchi samples (diameter, 0.5 to 1 mm) from 20 patients. pD2 was 7.7 +/- 0.1 (pD2 = - log EC50) and maximal effect (Emax) was 36.2 +/- 4.7% of the maximal response to acetylcholine. The B2 agonist [Hyp3TyrMe8]Bk contracted airway smooth muscle with a pD2 of 7.8 +/- 0.2 and an Emax of 39 +/- 9%. The B1 agonist [Sar1dPhe8desArg9]Bk induced only a weak contraction at 10(-6) M. The effect of Bk was abolished by the B2 (Hoe 140) but not by the B1 [Leu8desArg9]Bk receptor antagonist. Indomethacin 10(-6) M abolished Bk-induced contraction, suggesting that cyclooxygenase products are involved in Bk action. Capsaicin 10(-5) M, which selectively depletes C fibers from airway mediators through the ruthenium red pathway, and ruthenium red 10(-5) M significantly inhibited the concentration-response curves to Bk. However, tetrodotoxin (+/-)-CP-96,345, SR 48968, and atropine did not significantly affect Bk concentration-response curves, suggesting that nerve conduction, substance P (SP), neurokinin A (NKA), and acetylcholine release are not involved in Bk action. Our data indicate that Bk contracts human distal airway smooth muscle through the Bk B2 receptor and a cyclooxygenase pathway. This effect appears to involve capsaicin and ruthenium red pathways but neither acetylcholine nor NKA and SP release.

This article has been cited by other articles:

				R. Laporte, A. Hui, and I. Laher Pharmacological Modulation of Sarcoplasmic Reticulum Function in Smooth Muscle Pharmacol. Rev., December 1, 2004; 56(4): 439 - 513. [Abstract] [Full Text] [PDF]

				B.-C. Chen, C.-C. Yu, H.-C. Lei, M.-S. Chang, M.-J. Hsu, C.-L. Huang, M.-C. Chen, J.-R. Sheu, T.-F. Chen, T.-L. Chen, et al. Bradykinin B2 Receptor Mediates NF-{kappa}B Activation and Cyclooxygenase-2 Expression via the Ras/Raf-1/ERK Pathway in Human Airway Epithelial Cells J. Immunol., October 15, 2004; 173(8): 5219 - 5228. [Abstract] [Full Text] [PDF]

				G.F. Joos and B. O'Connor Indirect airway challenges Eur. Respir. J., June 1, 2003; 21(6): 1050 - 1068. [Abstract] [Full Text] [PDF]

				A. Szallasi and P. M. Blumberg Vanilloid (Capsaicin) Receptors and Mechanisms Pharmacol. Rev., June 1, 1999; 51(2): 159 - 212. [Abstract] [Full Text] [PDF]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				J. L. Szarek, B. Spurlock, C. A. Gruetter, and S. Lemke Substance P and capsaicin release prostaglandin E2 from rat intrapulmonary bronchi Am J Physiol Lung Cell Mol Physiol, November 1, 1998; 275(5): L1006 - L1012. [Abstract] [Full Text] [PDF]

				Z. K. Pan, R. D. Ye, S. C. Christiansen, M. A. Jagels, G. M. Bokoch, and B. L. Zuraw Role of the Rho GTPase in Bradykinin-Stimulated Nuclear Factor-{kappa}B Activation and IL-1{beta} Gene Expression in Cultured Human Epithelial Cells J. Immunol., March 15, 1998; 160(6): 3038 - 3045. [Abstract] [Full Text] [PDF]

				L. Pang and A. J. Knox PGE2 release by bradykinin in human airway smooth muscle cells: involvement of cyclooxygenase-2 induction Am J Physiol Lung Cell Mol Physiol, December 1, 1997; 273(6): L1132 - L1140. [Abstract] [Full Text] [PDF]